The 16th MedTech Investing Europe Conference

25 & 26 April 2013 • MCH Beaulieu, Lausanne, Switzerland

Bringing together innovators, leading investors and major healthcare corporations

www.medtechinvesting.com

In Partnership with Sponsored by

Who should attend The delegate profile is made up of the following individuals:

Investors with a core interest in MedTech

Senior representatives from major healthcare corporations

MedTech start-ups seeking financing

Family offices and private investors

MedTech service providers

2012 Attendance

Featured Workshop and Roundtable

How to Attract Funding and Successfully Develop Your Technology

A unique free-to-attend interactive workshop session for technology providers and investors alike. Learn what makes a successful technology company, what do investors want to see and how to attract investors for current and later rounds.

Closed Door Family OfficeRoundtable

This exclusive roundtable is open only for qualifying family office delegates. Led by Canton of Vaud and Polytech Advisors, this invitation-only roundtable explores the opportunities for private investors in new technologies in Switzerland.

About the event Now in its 16th edition, The MedTech Investing Europe Conference offers a perfect combination of the latest investment opportunities in game-changing technologies and unrivalled programme content giving first-hand insight and opinion from senior-level MedTech experts.

Pre-arranged one-to-one meetings and extensive networking opportunities will give investors and entrepreneurs ample opportunity to identify and meet with the companies and individuals that are right for you. This year’s agenda has been comprehensively researched and designed to cover the most up to date issues within this ever-developing sector and will provide delegates with the vital intelligence and advice needed to succeed in 2013 and beyond.

Supported by PR Partner

VC/Private Equity/Fund Managers/ Other Private Investors

Healthcare Corporates Presenting Companies Government/Academia/Industry Consulting/Other

UK Rest of Europe USA Rest of World

follow us @MTI_Europe for the latest MTI updates and industry news.

Media Partner

Innovators and technology providers looking for investment partnering include:

Benefits of attending Exclusive access to over 40 pioneering MedTech innovators who will showcase their latest innovations and provide investors with a diverse range of opportunities for investment. The presentations will be streamed for the benefit of the audience and will include product information, stage of business, expected growth rates, exit strategy plans and the level of funding required.

Private one-to-one meetings with the innovators and investors of your choice to discuss potential business opportunities and foster future relationships. Last year over 200 meetings were booked through our online networker, which will allow you to control your conference experience and make the most of your one-to-one meeting time by pre-arranging your twenty minute meetings with MedTech entrepreneurs and other industry leaders.

Exclusive roundtable discussions and keynote presentations have been designed with industry experts to provide you with all the necessary information and guidance you need to flourish in today’s economic climate. Key sessions include:

Investor Panel – Structuring Investments for Success

Global Outlook – Expanding the Scope of New Technologies

Mergers & Acquisitions and Strategic Alliances

Tomorrow’s Game Changers

Future of MedTech Investment

Great peer-to-peer networking opportunities with leading investors, major healthcare corporations and medical technology companies who will all be reunited under one roof, offering a chance to discuss new business opportunities.

More presenting companies are signing up every week, so please check on the website for an updated list: www.medtechinvesting.com

smart tracking solutions

Enlightening Healthcare

08:30 – 09:30 Registration, refreshments and networking

09:30 – 09:40 Welcome from the State of VaudRaphaël Conz • Economic Promotion Manager, State of Vaud, Switzerland

09:40 – 09:50 Chairman’s opening remarks

09:50 – 10:20 MedTech Sector “State of the Nation” Address

Where is the MedTech sector today and what changes have we seen in the last 12 months? From an arguable blurring of the boundaries between MedTech and other life science elements, to a greater emphasis on disruptive technologies, how has the MedTech investment landscape developed and where is the industry headed?

10:20 – 11:10 Investor Panel – Structuring Investments for Success

Whether supporting start-ups through angel investment or bringing targeted investment from specialist managed funds, as the MedTech sector continues to remould and reshape, sources of investment in entrepreneurs and their technology will change too. Where are the next waves of investment coming from and how can these be structured to secure success?

How specialist insight and experience from managed funds strengthens the investment Angel investment – getting new technology off the ground The venture capital cycle and where priorities lie

Dr Lukas Günther • Principal, Wellington Partners, GermanyJonathan Goldstein • Israel Editor, Medical Device Daily, Israel

11:10 – 11:30 Morning coffee and networking opportunity

11:30 – 12:30 MedTech companies pitch their investment opportunities Venues: Rooms 1 & 2

These sessions are dedicated to MedTech companies presenting innovative technology and investment opportunities in different sectors to an audience of investors. Each company will present for 10 minutes.

12:30 – 13:30 Workshop & Roundtable Sessions

How to Attract Funding and Successfully Develop Your Technology Interactive workshop session for technology providers and investors alike. Learn what makes a successful technology company, what do investors want to see and how to attract investors for current and later rounds.

Closed Door Family OfficeRoundtableLed by Canton of Vaud and Polytech Advisors, this invitation-only roundtable explores the opportunities for private investors in new technologies in Switzerland.

CONFERENCE PROGRAMME – DAY ONEThursday 25 April 2013

13:30 – 14:10 Lunch and networking opportunity

14:10 – 15:10 MedTech companies pitch their investment opportunities Venues: Rooms 1 & 2

These sessions are dedicated to MedTech companies presenting innovative technology and investment opportunities in different sectors to an audience of investors. Each company will present for 10 minutes.

15:10 – 16:30 ONE-2-ONE: Special pre-scheduled individual One-2-One meetings will be taking place in our dedicated meeting areaVenue: Salle Oslo

16:30 – 16:45 Afternoon coffee and networking opportunity

16:45 – 17:45 Global Outlook – Expanding the Scope of New Technologies

Growth potential in emerging markets continues to be an attractive solution to maximising technology commercialisation. But how can you take advantage of emerging market potential and should there be a more global outlook in developing technologies?

Overcoming barriers to entry – successfully negotiating foreign policy and regulation Building clinical trials for a global market How does the rise of emerging markets affect traditional investment frameworks?

Matthieu Cuche • Market Access & Health Economics Director, Vascular Therapies EMEA, Covidien, SwitzerlandCorinne Lebourgeois • Co-Founder, MedC. Partners, Switzerland

17:45 – 17:50 Chairman’s Day One Closing Remarks

18:00 – 19:30 Networking Drinks Reception

08:30 – 09:00 Registration, refreshments and networking

09:00 – 09:10 Chairman’s opening remarks

09:10 – 10:20 Mergers & Acquisitions and Strategic Alliances

It has been argued that the structure of the MedTech industry is undergoing some significant changes resulting in a heavier reliance on M&A and strategic partnerships. So what are MedTech companies looking for and how can developers of technology attract their attention?

Competition for new technologies – is it a seller’s market? How can M&A deals be structured for success of both parties? Are synergies between companies essential and how can different cultures and business models be incorporated

together?David Atkins • VP International, Mentor & Acclarent, Johnson & Johnson, UKTownsend Goddard • Director, Business Development & Strategic Planning, Stryker Europe, Switzerland

10:20 – 11:10 MedTech companies pitch their investment opportunities Venues: Rooms 1 & 2

These sessions are dedicated to MedTech companies presenting innovative technology and investment opportunities in different sectors to an audience of investors. Each company will present for 10 minutes.  

11:10 – 11:30 Morning coffee and networking opportunity

11:30 – 13:00 ONE-2-ONE: Special pre-scheduled individual One-2-One meetings will be taking place in our dedicated meeting areaVenue: Salle Oslo

13:00 – 13:40 Lunch and networking opportunity

13:40 – 14:30 MedTech companies pitch their investment opportunities Venues: Rooms 1 & 2

These sessions are dedicated to MedTech companies presenting innovative technology and investment opportunities in different sectors to an audience of investors. Each company will present for 10 minutes.

CONFERENCE PROGRAMME – DAY TWOFriday 26 April 2013

“Both the number of investors and their calibre proved unrivalled in what was a thoroughly enjoyable and productive conference.

Sameer Kothari, Chief Executive, Zilico Ltd.

MTI Europe is in my view a ‘must-attend’ event for anyone involved in building medical device startups.

It significantly contributes to the effort of fostering a much-needed ecosystem of startups, executives, VCs, corporates and service providers in the European MedTech space.

Aris Constantinides, Investment Director, NBGI Ventures

We found the event very valuable and were very impressed with the calibre of the entrepreneurs and the good turn out from corporates and VCs too. A massive thank you from us!

Hazel Moore, Chairman & Founder, First Capital

14:30 – 15:30 Tomorrow’s Game Changers

Advancements in technology can take many forms from revolutionising an entire sector to simply improving existing methods of practice. What are current trends in technology development and where might investors find the best returns?

Where are next-gen technologies likely to originate and how can they be fostered? What will investors need to see before investing in a new technology? The practitioner’s view – where is demand shifting? Beyond technology – how is traditional healthcare provision changing?

Raman Minhas • Director, ATPBio, UKAngelo De Rosa • Head of Strategy & Business Development, Medtronic, SwitzerlandSenior Representative, AAL Joint Programme, Belgium

15:30 – 16:00 Future of MedTech Investment

What lies in wait for investors and entrepreneurs over the coming 12 months? In this closing panel future trends and lessons from experience will be discussed to give you unique insight into likely trends, opportunities and challenges.Benoit Dubuis • President, BioAlps; Director, Eclosion SA, Switzerland

16:00 End of conference

“

“

”

”

”

Feedback from previous MedTech Investing Europe events:

Ticket Options

Early Bird Discount: £849 / €1019 (book before 15 March 2013)

Standard Price: £999 / €1199 (from 16 March 2013)

Group tickets are also available; please visit our website for more information

How to RegisterVisit www.medtechinvesting.com and click on ‘Book Now’

Email: callsumaali@campden.comCall: +44 (0)207 214 0519

Interested in becoming a presenting company?Present your investment opportunity to an audience of private investors, venture capital and private equity partners and blue-chip corporations.

For more information on presenting company opportunities please contactMax Garry on +44 (0)207 214 0673

or email at maxgarry@campden.com

Organised by

140 London Wall, London, EC2Y 5DN, UKTel: +44 (0) 20 7214 0519 Fax: +44 (0) 20 7214 0512

email: conferences@campden.com www.campdenconferences.com

The 16th MedTech Investing Europe Conference

Scan the QR code for the latest MTI updates

@MTI_Europe